Page 23 - Cronos Group News Today

U.S. Assistant Secretary of Health Rachel Levine has recommended easing restrictions on marijuana, Bloomberg News reported on Wednesday citing a letter. The Department of Health and...

Marijuana is currently classified as a Schedule I drug.

Nearly 40 U.S. states have legalized marijuana use in some form, but it remains completely illegal in some states and at the federal level. Reclassifying marijuana as less harmful than drugs like heroin would be a first step toward wider legalization, a move backed by a majority of Americans. The scheduling recommendation for marijuana was provided to the Drug Enforcement Agency (DEA) on Tuesday as part of President Biden's directive to HHS, the spokesperson said.

The U.S. Department of Health and Human Services (HHS) has recommended easing restrictions on marijuana, Bloomberg News reported on Wednesday, citing a letter.

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

(Reuters) -A senior Department of Health and Human Services (HHS) official has recommended easing restrictions on marijuana, Bloomberg News reported o...

Cronos Group Inc (NASDAQ: CRON) shares are trading higher by 6.9% to $1.86 Wednesday afternoon amid strength in the broader cannabis sector. Shares of cannabis stocks are trading higher following a

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

Nearly 40 U.S. states have legalized marijuana use in some form, but it remains completely illegal in some states and at the federal level. Reclassifying marijuana as less harmful than drugs like heroin would be a first step toward wider legalization, a move backed by a majority of Americans. The scheduling recommendation for marijuana was provided to the Drug Enforcement Agency (DEA) on Tuesday as part of President Biden's directive to HHS, the spokesperson said.